U.S. Other Utilities Stock News

Dover (DOV) is back in focus after its latest quarterly results, with second quarter sales reaching US$2,190.02 million and net income of US$312.25 million, supported by stronger performance in Asia than in Europe. See our latest analysis for Dover. The latest earnings release came as the share price eased, with Dover’s stock falling around 10% over the past month and drifting lower over the past quarter, even though the 1 year total shareholder return of 11.49% and 3 year total shareholder...

Kilroy Realty stock slipped about 1.9% to US$38.66 after its Q2 report, which keeps the 7 day move slightly in the red but leaves the 90 day run still firmly positive. The headline from this quarter is a profit squeeze. Funds From Operations per share, the core yardstick for office real estate investment trusts, printed at US$0.93, well below where it sat in mid 2025. Net income for the quarter came in at US$19.9m, a sharp step down from last year’s peaks. Short term traders are reacting to...

Traders just marked Axalta Coating Systems up roughly 5% in a single session, yet the real story sits inside the margin sheet. Q2 brought record adjusted earnings before interest, taxes, depreciation and amortization of US$305 million and a Q2 high adjusted EBITDA margin of 22.7%. The question is whether this jump in the stock is simply momentum or a rational reprice of a coatings business that is squeezing more profit out of each dollar of sales. Is Axalta Coating Systems trading at a...

MakeMyTrip stock edged up 2.6% to US$53.72 after earnings, a modest move for a company priced on big growth expectations and a trailing P/E near 97x. The headline this quarter is not the share price pop. It is the strain between rich valuation, a thinner net profit margin of 5% over the last year and weak interest coverage. Investors are being asked to pay well above an estimated cash flow value for MakeMyTrip while accepting a business that currently converts far less of its large booking...

Incyte stock just jumped 9.3% in a single session, yet the real story is not the share price spike. The company delivered what the market has been waiting for in biotech, with revenue for Q2 2026 reaching US$1.67b and basic earnings per share at US$2.92. The one day move reflects investors suddenly pricing in a business that now appears more profitable and more diversified than it did even a few quarters ago. Impressed by Incyte’s Q2 2026 earnings strength but want more stocks that pair solid...

In July 2026, First Interstate BancSystem reported second-quarter 2026 net income of US$83.9 million and diluted earnings per share of US$0.87, while also disclosing higher net loan charge-offs of US$9.7 million and announcing a US$0.47 quarterly dividend. Over the same period, the board completed a share repurchase of approximately 7.98 million shares and expanded its buyback authorization to US$450 million, signalling continued use of capital returns alongside board refreshment with two...

Recent coverage in July 2026 highlighted that Macy’s is now rated a Zacks Rank #1 (Strong Buy), with earnings estimates revised higher and valuation metrics such as P/E, P/B and P/CF suggesting the stock is trading at an attractive discount to industry peers. At the same time, Macy’s appointment of Alexandre Choueiri to lead Bluemercury is reshaping how investors view its presence in prestige beauty and the company’s overall business mix. We’ll now examine how Macy’s perceived...

In recent months, MetLife has expanded financial access by deepening bancassurance partnerships with banks across multiple markets, embedding insurance solutions into everyday financial products through technology. This push to integrate protection into routine banking and consumer transactions highlights how MetLife is broadening its customer base and tailoring coverage to varied groups, from young adults to seniors and caregivers. We’ll now examine how this push into technology-enabled...

iRhythm Holdings (IRTC) is back on investor radars after recent trading, with the stock closing at US$117.37. The move comes against a backdrop of mixed short and longer term share price performance. See our latest analysis for iRhythm Holdings. The strong 1 day share price return of 4.65% and 7 day share price return of 7.68% come after a weaker run, with the year to date share price return down 33.02% and the 1 year total shareholder return down 14.18%. However, the 5 year total shareholder...

Metropolitan Bank Holding Corp. recently reported its second-quarter 2026 results, with net interest income rising to US$90.45 million and net income edging up to US$19.22 million, while basic earnings per share from continuing operations eased to US$1.55 from US$1.78 a year earlier. Across the first half of 2026, the bank’s net income increased to US$50.65 million and diluted earnings per share from continuing operations reached US$4.40, alongside a board-approved quarterly dividend...

Tech stocks are under pressure after a sharp global semiconductor sell off, yet many investors are looking at the other side of their portfolios. Large consumer staples stocks can sometimes offer a steadier ride when chip stocks swing sharply. This article focuses on three companies from a Defensive Consumer Staples Stocks screener that appear closely exposed to the current news backdrop, whether through their role in everyday spending or their perceived lower risk profile. You will see how...

Why Capital Southwest Stock Is Back On Investor Radars Capital Southwest (CSWC) is drawing attention after expectations of higher revenues and a possible earnings beat coincided with preliminary net investment income guidance and ongoing proxy efforts around its authorized share count. See our latest analysis for Capital Southwest. At a latest share price of $23.82, Capital Southwest has seen a 30 day share price return of 2.89% and a year to date share price return of 6.86%. The 1 year total...

Outlook Therapeutics recently received U.S. FDA approval for LYTENAVA (bevacizumab‑vikg) to treat neovascular (wet) age-related macular degeneration, making it the first and only FDA‑approved ophthalmic bevacizumab in the U.S. retina market. This approval, which the company believes qualifies LYTENAVA for 12 years of Reference Product Exclusivity under the Biologics Price Competition and Innovation Act, positions Outlook Therapeutics in an approximately US$8.50 billion annual U.S. anti‑VEGF...

Evercore Inc. reported its Q2 2026 results on July 29, 2026, holding its earnings call the same day after releasing numbers before the US market opened. The market’s focus is on Evercore’s upcoming revenue growth expectations and its history of outperforming analyst estimates, which together are shaping sentiment ahead of this earnings season. We’ll now explore how Evercore’s upcoming Q2 earnings report and history of beating expectations could influence its broader investment...

Affiliated Managers Group recently issued guidance for its second-quarter 2026 results, indicating an adjusted EBITDA range of US$290 million to US$305 million and highlighting continued strength in its earnings surprise track record. The company’s current Zacks Rank #2 (Buy) and positive Earnings ESP of 1.86% have reinforced investor focus on how its diversified affiliates may sustain performance. We’ll now examine how AMG’s guided adjusted EBITDA range for the quarter may influence its...

Recent market interest in Host Hotels & Resorts (HST) has picked up as investors assess its role as a large US hotel-focused REIT, with attention on recent share performance and current valuation metrics. See our latest analysis for Host Hotels & Resorts. Host Hotels & Resorts shares recently closed at $25.47, with solid short term momentum reflected in a 2% 1 day share price return and 4.21% 7 day share price return, while a 69.32% 1 year total shareholder return and 104.79% 5 year total...

Synaptics stock has delivered a strong 70.9% return over the past year, yet its valuation picture is split, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to a premium while traditional market multiples suggest the shares may still be priced attractively. Over the past 12 months Synaptics has returned 70.9%, which places recent share price momentum firmly on the positive side for existing holders. Future growth in cash flows from Synaptics' semiconductor solutions can...

Astronics Corporation recently received a favorable ruling from a UK appellate court in its patent dispute with Lufthansa Technik AG, which dismissed Lufthansa Technik’s appeal and ordered a partial refund to Astronics. This court outcome not only returns cash to Astronics but also strengthens the company’s legal position around its intellectual property protection efforts. We’ll now examine how this favorable patent ruling, including the ordered partial refund, reshapes Astronics’ existing...

Zions Bancorporation, National Association recently completed a US$500,000,000 fixed-to-floating rate senior note offering due October 1, 2029, while also reporting second-quarter 2026 results that showed higher net interest income and net income versus the prior year. Alongside this earnings strength, Zions finished a US$75,000,000 share repurchase program in the quarter, signaling active balance sheet and capital management. With these stronger quarterly earnings and completed buybacks,...

First Guaranty Bancshares stock inched up about 3% to US$9.64 after its second quarter report, a modest move for a bank that has put investors through sharp swings over the past year. The market reaction looks calm on the surface, yet the headline is more dramatic. Earnings per share landed at roughly US$0.17 and net income reached about US$2.8 million, while non performing loans continued to weigh on the story. The key issue is how long this repair job on credit quality and profitability can...

InterDigital stock has delivered a very large 5 year return, yet the latest valuation checks paint a more mixed picture, which raises questions about how much of that progress is already reflected in the current price. Over the past 5 years, InterDigital shares have gained about 308%, which puts long term holders in a strong position but makes the current entry point more sensitive to valuation assumptions. Recent moves to extend its patent licensing into connected EV chargers and highlight...

Applied Optoelectronics stock has delivered an extremely strong three year return, yet current valuation work suggests the market price may still sit below an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach and supported by earnings multiples. Over the past three years, Applied Optoelectronics has returned about 11x, which puts a lot of focus on whether that gain is justified by the company’s long term cash generation potential. Future revenue growth and cash flow...

Eaton stock has returned 156.9% over the past five years, yet the latest valuation checks send a mixed signal, with the Discounted Cash Flow (DCF) intrinsic value suggesting the shares trade at a premium while the earnings multiple view appears more supportive. A 156.9% gain over five years highlights how strongly Eaton has rewarded long term holders, which raises the bar for what counts as good value today. Recent moves to expand additive manufacturing in Europe and sharpen focus on energy...

Simpson Manufacturing stock shrugged off its recent 30 day slump, rising 2.6% today, because the quarter landed squarely on the one thing this housing exposed manufacturer is increasingly being judged on: profitability. Q2 net sales reached US$671.1m, but the real story was earnings power, with net income of US$127.0m and an operating margin of 25.2% that leaned on tight cost control and mix rather than volume. For a company often viewed as a steady building products supplier, this kind of...